Santen Pharmaceutical Co (4536N) Revenue

0 Followers

Santen Pharmaceutical Co Revenue

Santen Pharmaceutical Co had a revenue of 69.14B in the quarter ending Sep 30, 2026, with 0.59%. This bring the company's revenue in the last twelve months to 291.48B, Increased -0.85%. In the fiscal year ending Mar 31, 2026, Santen Pharmaceutical Co had annual revenue of 300.00B with 2.87% growth.

Revenue (ttm)

291.48B

Revenue Growth

-12.40%

P/S Ratio

0.21

Revenue/Employee

$75,605,847

Employees

3,968

Market Cap

$63.74B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	300.00B	8.38B	+2.87%
Mar 31, 2026	291.62B	-10.34B	-3.42%
Mar 31, 2025	301.96B	22.93B	+8.22%
Mar 31, 2024	279.04B	12.78B	+4.80%
Mar 31, 2023	266.26B	16.65B	+6.67%
Mar 31, 2022	249.60B	8.05B	+3.33%
Mar 31, 2021	241.56B	7.53B	+3.22%
Mar 31, 2020	234.03B	9.08B	+4.04%
Mar 31, 2019	224.94B	25.85B	+12.98%
Mar 31, 2017	199.10B	―	―